Brett G Angel1, Heath Saltzman2, Luke S Kusmirek2. 1. Division of Cardiology, Hahnemann University Hospital, Drexel University College of Medicine, 245 North 15th Street, Suite 6122, Philadelphia, PA, 19102, USA. bga26@drexel.edu. 2. Division of Cardiology, Hahnemann University Hospital, Drexel University College of Medicine, 245 North 15th Street, Suite 6122, Philadelphia, PA, 19102, USA.
Abstract
PURPOSE OF REVIEW: Medical devices have become an integral part of comprehensive heart failure management. Not all heart failure patients, however, accrue benefit from every new device, and even with extensive practice guidelines, this remains an evolving field. RECENT FINDINGS: The addition of implantable devices, like internal cardioverter defibrillators (ICDs), and novel pacing technologies, including cardiac resynchronization therapy (CRT), have helped to compliment goal-directed medical therapy and positively impact prognosis in multiple high-quality clinical trials. This review attempts to summarize the rapidly evolving literature with respect to existing device guidelines for routine implantable devices as well as some available and future technologies that are not yet a part of routine guidelines. ICD, CRT, and other implantable devices continue to save lives, decrease hospitalizations, and evolve the management of patients with heart failure beyond the capabilities of optimal guideline-directed medical therapy alone.
PURPOSE OF REVIEW: Medical devices have become an integral part of comprehensive heart failure management. Not all heart failurepatients, however, accrue benefit from every new device, and even with extensive practice guidelines, this remains an evolving field. RECENT FINDINGS: The addition of implantable devices, like internal cardioverter defibrillators (ICDs), and novel pacing technologies, including cardiac resynchronization therapy (CRT), have helped to compliment goal-directed medical therapy and positively impact prognosis in multiple high-quality clinical trials. This review attempts to summarize the rapidly evolving literature with respect to existing device guidelines for routine implantable devices as well as some available and future technologies that are not yet a part of routine guidelines. ICD, CRT, and other implantable devices continue to save lives, decrease hospitalizations, and evolve the management of patients with heart failure beyond the capabilities of optimal guideline-directed medical therapy alone.
Entities:
Keywords:
Cardiac resynchronization therapy (CRT); Dyssynchrony; Internal cardioverter defibrillator (ICD); Left bundle branch block (LBBB); Sudden cardiac death (SCD); Systolic heart failure; Ventricular tachycardia and fibrillation
Authors: Ilan Goldenberg; Arthur J Moss; Scott McNitt; Wojciech Zareba; W Jackson Hall; Mark L Andrews; David J Wilber; Helmut U Klein Journal: J Am Coll Cardiol Date: 2006-04-17 Impact factor: 24.094
Authors: S J Connolly; M Gent; R S Roberts; P Dorian; D Roy; R S Sheldon; L B Mitchell; M S Green; G J Klein; B O'Brien Journal: Circulation Date: 2000-03-21 Impact factor: 29.690
Authors: Michael R Gold; Christophe Thébault; Cecilia Linde; William T Abraham; Bart Gerritse; Stefano Ghio; Martin St John Sutton; Jean-Claude Daubert Journal: Circulation Date: 2012-07-10 Impact factor: 29.690
Authors: Alan Kadish; Alan Dyer; James P Daubert; Rebecca Quigg; N A Mark Estes; Kelley P Anderson; Hugh Calkins; David Hoch; Jeffrey Goldberger; Alaa Shalaby; William E Sanders; Andi Schaechter; Joseph H Levine Journal: N Engl J Med Date: 2004-05-20 Impact factor: 91.245